Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Healthcare Facilities & Services

Market Closed - Euronext Paris Other stock markets 11:35:10 2024-07-17 am EDT			After market 03:31:15 pm
48.3 ^EUR	+1.53%		48.24	-0.12%

Jul. 15	Eurofins: dispute with SGS over termination of contract	CF
Jul. 11	Eurofins: further clarifications for the market	CF

Eurofins Scientific SE acquired all assets from Omega Diagnostics GmbH.

January 02, 2019

Eurofins Scientific SE (ENXTPA:ERF) acquired all assets from Omega Diagnostics GmbH January 3, 2019. Eurofins will continue the Reinbek-based company under the name Immunnolab Clinical Diagnostics GmbH. The jobs at the Reinbek site are retained. Eurofins Scientific SE (ENXTPA:ERF) completed the acquisition of all assets from Omega Diagnostics GmbH January 3, 2019.

Latest news about Eurofins Scientific SE

Eurofins: dispute with SGS over termination of contract	Jul. 15	CF
Eurofins: further clarifications for the market	Jul. 11	CF
Eurofins to share more details on real estate programme in response to Muddy Waters	Jul. 11	RE
Eurofins says it is ready to detail its real estate program in response to Muddy Waters	Jul. 11	RE
Eurofins Scientific SE acquired LABORMAR.	Jul. 07	CI
North American Morning Briefing : Stock Futures Tick Higher Before Payrolls Data	Jul. 05	DJ
Eurofins: Muddy Waters' accusations again rejected	Jul. 05	CF
Eurofins Scientific Issues Second Rebuttal of Muddy Waters Allegations	Jul. 03	MT
CAC40: up sharply despite gloomy PMIs	Jul. 03	CF
Europe rebounds ahead of PMIs, supported by Powell	Jul. 03	RE
Eurofins once again refutes Muddy Waters' allegations	Jul. 03	RE
Eurofins: second denial of MW accusations	Jul. 03	CF
New semester, new state of mind	Jul. 01
Eurofins Scientific Unit to Sell Nightingale's Blood Analysis test in the US	Jun. 28	MT
Market Update-Europe closes lower in a session marked by a wait-and-see attitude	Jun. 25	RE
EUROFINS : Oddo BHF confirms its recommendation on the stock	Jun. 25	CF
European shares fall as Airbus hammers aerospace shares, tech slips	Jun. 25	RE
Eurofins: Muddy Waters' accusations rejected	Jun. 25	CF
Europe in the red with tech and political risk	Jun. 25	RE
Eurofins denies allegations of embezzlement by Muddy Waters	Jun. 25	RE
EUROFINS SCIENTIFIC : Eurofins’ share price tanks after short seller report	Jun. 24
European shares start the week higher on autos, banks	Jun. 24	RE
Eurofins Scientific Faces Alleged 'Material Overstatements' from Muddy Waters Research	Jun. 24	MT
MORNING BID AMERICAS-Transatlantic split reopens as half-year nears	Jun. 24	RE
Lab testing firm Eurofins slumps after Muddy Waters report, short position	Jun. 24	RE

Chart Eurofins Scientific SE

Duration

Period

More charts

Company Profile

Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).

Sector

Healthcare Facilities & Services

Calendar

2024-07-24 - Q2 2024 Earnings Release

Related indices

CAC 40 , STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

EUROFINS SCIENTIFIC : Eurofins’ share price tanks after short seller report

June 24, 2024 at 12:46 pm EDT

More Strategies

Ratings for Eurofins Scientific SE

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

47.57 EUR

Average target price

59.69 EUR

Spread / Average Target

+25.47%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
EUROFINS SCIENTIFIC SE	-18.11%	9.98B
HCA HEALTHCARE, INC.	+19.05%	83.53B
CVS HEALTH CORPORATION	-21.61%	75.4B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.32%	26.73B
LABCORP HOLDINGS INC.	-4.41%	18.25B
FRESENIUS SE & CO. KGAA	+6.95%	18.12B
QUEST DIAGNOSTICS INCORPORATED	+7.88%	16.51B
NATERA, INC.	+78.45%	14.05B
TENET HEALTHCARE CORPORATION	+76.06%	13.03B
PURE HEALTH HOLDING	-27.89%	12.67B

Other Healthcare Facilities & Services